Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine LR Baden, HM El Sahly, B Essink, K Kotloff, S Frey, R Novak, D Diemert, ... New England journal of medicine 384 (5), 403-416, 2021 | 10060 | 2021 |
An mRNA vaccine against SARS-CoV-2—preliminary report LA Jackson, EJ Anderson, NG Rouphael, PC Roberts, M Makhene, ... New England journal of medicine 383 (20), 1920-1931, 2020 | 3484 | 2020 |
Baricitinib plus remdesivir for hospitalized adults with Covid-19 AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ... New England Journal of Medicine 384 (9), 795-807, 2021 | 1770 | 2021 |
Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults EJ Anderson, NG Rouphael, AT Widge, LA Jackson, PC Roberts, ... New England Journal of Medicine 383 (25), 2427-2438, 2020 | 1606 | 2020 |
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans PS Arunachalam, F Wimmers, CKP Mok, RAPM Perera, M Scott, T Hagan, ... Science 369 (6508), 1210-1220, 2020 | 1069 | 2020 |
The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients L Premkumar, B Segovia-Chumbez, R Jadi, DR Martinez, R Raut, ... Science immunology 5 (48), eabc8413, 2020 | 877 | 2020 |
Durability of responses after SARS-CoV-2 mRNA-1273 vaccination AT Widge, NG Rouphael, LA Jackson, EJ Anderson, PC Roberts, ... New England Journal of Medicine 384 (1), 80-82, 2021 | 815 | 2021 |
Infections associated with haemophagocytic syndrome NG Rouphael, NJ Talati, C Vaughan, K Cunningham, R Moreira, C Gould The Lancet infectious diseases 7 (12), 814-822, 2007 | 719 | 2007 |
Molecular signatures of antibody responses derived from a systems biology study of five human vaccines S Li, N Rouphael, S Duraisingham, S Romero-Steiner, S Presnell, ... Nature immunology 15 (2), 195-204, 2014 | 718 | 2014 |
Antibody persistence through 6 months after the second dose of mRNA-1273 vaccine for Covid-19 N Doria-Rose, MS Suthar, M Makowski, S O’Connell, AB McDermott, ... New England Journal of Medicine 384 (23), 2259-2261, 2021 | 694 | 2021 |
Rapid generation of neutralizing antibody responses in COVID-19 patients MS Suthar, MG Zimmerman, RC Kauffman, G Mantus, SL Linderman, ... Cell Reports Medicine 1 (3), 2020 | 542 | 2020 |
Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants A Pegu, SE O’Connell, SD Schmidt, S O’Dell, CA Talana, L Lai, J Albert, ... Science 373 (6561), 1372-1377, 2021 | 522 | 2021 |
Neisseria meningitidis: Biology, Microbiology, and Epidemiology NG Rouphael, DS Stephens Neisseria meningitidis: advanced methods and protocols, 1-20, 2012 | 489 | 2012 |
Antibiotics-driven gut microbiome perturbation alters immunity to vaccines in humans T Hagan, M Cortese, N Rouphael, C Boudreau, C Linde, MS Maddur, ... Cell 178 (6), 1313-1328. e13, 2019 | 464 | 2019 |
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells KW Cohen, SL Linderman, Z Moodie, J Czartoski, L Lai, G Mantus, ... Cell Reports Medicine 2 (7), 2021 | 401 | 2021 |
The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled … NG Rouphael, M Paine, R Mosley, S Henry, DV McAllister, H Kalluri, ... The Lancet 390 (10095), 649-658, 2017 | 381 | 2017 |
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials MR Gaudinski, KV Houser, KM Morabito, Z Hu, G Yamshchikov, ... The Lancet 391 (10120), 552-562, 2018 | 304 | 2018 |
Systems analysis of immunity to influenza vaccination across multiple years and in diverse populations reveals shared molecular signatures HI Nakaya, T Hagan, SS Duraisingham, EK Lee, M Kwissa, N Rouphael, ... Immunity 43 (6), 1186-1198, 2015 | 300 | 2015 |
Development of a definition of postacute sequelae of SARS-CoV-2 infection T Thaweethai, SE Jolley, EW Karlson, EB Levitan, B Levy, GA McComsey, ... Jama 329 (22), 1934-1946, 2023 | 264 | 2023 |
Viral infections associated with haemophagocytic syndrome NR Maakaroun, A Moanna, JT Jacob, H Albrecht Reviews in medical virology 20 (2), 93-105, 2010 | 263 | 2010 |